Accéder au contenu
Merck

A simple and efficient in vitro method for metabolism studies of radiotracers.

Nuclear medicine and biology (2001-06-08)
S Y Lee, Y S Choe, D H Kim, B N Park, S E Kim, Y Choi, K H Lee, J Lee, B T Kim
RÉSUMÉ

In vitro metabolism of acetylcholinesterase inhibitors containing 3-[(18)F]fluoromethylbenzyl- ([(18)F]1) and 4-[(18)F]fluorobenzyl-piperidine moieties ([(18)F]2) was studied and compared with the in vivo metabolism. Defluorination of the [(18)F]1 mainly occurred to generate [(18)F]fluoride ion both in vitro and in vivo. In contrast, the [(18)F]2 was converted into an unknown polar metabolite in both metabolism methods and another metabolite, 4-[(18)F]fluorobenzoic acid in vitro. These results demonstrated that the in vitro method can be used to predict the in vivo metabolism of both radiotracers.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
2-Fluorobenzoic acid, 97%